BACKGROUND:
METHODS:
RESULTS:
CONCLUSION:
Full article at: http://goo.gl/uXYkdc
By: Kayigamba FR1, Van Santen D2,3, Bakker MI4, Lammers J5, Mugisha V6, Bagiruwigize E7, De Naeyer L8, Asiimwe A9, Schim Van Der Loeff MF10,11,12.
- 1INTERACT, Kigali, Rwanda. fkaigamba@gmail.com.
- 2KIT Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands. dvsanten@ggd.amsterdam.nl.
- 3Public Health Service of Amsterdam (GGD), Amsterdam, The Netherlands. dvsanten@ggd.amsterdam.nl.
- 4KIT Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands. M.Bakker@kit.nl.
- 5Academic Medical Center (AMC), Amsterdam, The Netherlands. judith.lammers@amc.uva.nl.
- 6ICAP, Mailman School of Public Health, Columbia University, Kigali, Rwanda. vm2208@columbia.edu.
- 7Ruhengeri hospital, Ministry of Health, Kigali, Rwanda. emmanuelb@theaccessproject.com.
- 8INTERACT, Kigali, Rwanda. ldnaeyer@yahoo.com.
- 9University of Rwanda, Kigali, Rwanda. anita.asiimwe@gmail.com.
- 10Amsterdam Institute of Global Health and Development (AIGHD), Academic Medical Center (AMC), Amsterdam, The Netherlands. mschimvdloeff@ggd.amsterdam.nl.
- 11Center for Infection and Immunity Amsterdam (CINIMA), AMC, Amsterdam, The Netherlands. mschimvdloeff@ggd.amsterdam.nl.
- 12Public Health Service of Amsterdam (GGD), Amsterdam, The Netherlands. mschimvdloeff@ggd.amsterdam.nl.
More at: https://twitter.com/hiv insight
